Abstract |
The tumor suppressors Pten and p53 are frequently lost in breast cancer, yet the consequences of their combined inactivation are poorly understood. Here, we show that mammary-specific deletion of Pten via WAP-Cre, which targets alveolar progenitors, induced tumors with shortened latency compared to those induced by MMTV-Cre, which targets basal/ luminal progenitors. Combined Pten-p53 mutations accelerated formation of claudin-low, triple-negative-like breast cancer (TNBC) that exhibited hyper-activated AKT signaling and more mesenchymal features relative to Pten or p53 single-mutant tumors. Twenty-four genes that were significantly and differentially expressed between WAP-Cre:Pten/p53 and MMTV-Cre:Pten/p53 tumors predicted poor survival for claudin-low patients. Kinome screens identified eukaryotic elongation factor-2 kinase (eEF2K) inhibitors as more potent than PI3K/AKT/ mTOR inhibitors on both mouse and human Pten/p53-deficient TNBC cells. Sensitivity to eEF2K inhibition correlated with AKT pathway activity. eEF2K monotherapy suppressed growth of Pten/p53-deficient TNBC xenografts in vivo and cooperated with doxorubicin to efficiently kill tumor cells in vitro. Our results identify a prognostic signature for claudin-low patients and provide a rationale for using eEF2K inhibitors for treatment of TNBC with elevated AKT signaling.
|
Authors | Jeff C Liu, Veronique Voisin, Sharon Wang, Dong-Yu Wang, Robert A Jones, Alessandro Datti, David Uehling, Rima Al-awar, Sean E Egan, Gary D Bader, Ming Tsao, Tak W Mak, Eldad Zacksenhaus |
Journal | EMBO molecular medicine
(EMBO Mol Med)
Vol. 6
Issue 12
Pg. 1542-60
(Dec 2014)
ISSN: 1757-4684 [Electronic] England |
PMID | 25330770
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | © 2014 The Authors. Published under the terms of the CC BY 4.0 license. |
Chemical References |
- Enzyme Inhibitors
- Tumor Suppressor Protein p53
- Oncogene Protein v-akt
- Elongation Factor 2 Kinase
- PTEN Phosphohydrolase
|
Topics |
- Animals
- Elongation Factor 2 Kinase
(antagonists & inhibitors, genetics, metabolism)
- Enzyme Inhibitors
(pharmacology)
- Epithelium
(enzymology, metabolism)
- Female
- Gene Deletion
- Humans
- Mammary Glands, Human
(enzymology, metabolism)
- Mice
- Mice, Inbred C57BL
- Oncogene Protein v-akt
(genetics, metabolism)
- PTEN Phosphohydrolase
(genetics, metabolism)
- Triple Negative Breast Neoplasms
(drug therapy, enzymology, genetics)
- Tumor Suppressor Protein p53
(genetics, metabolism)
|